Per- and polyfluoroalkyl substances (PFAS) Accumulation in CKD: The Hidden Role of Albuminuria in Modifying Environmental Toxin Burden

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
Per- and polyfluoroalkyl substances (PFAS) Accumulation in CKD: The Hidden Role of Albuminuria in Modifying Environmental Toxin Burden

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Ping-Hsun
Wu
Ping-Hsun Wu 970392kmuh@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan *
Yi-Ting Lin emilyhei@gmail.com Kaohsiung Medical University Hospital Department of Family Medicine Kaohsiung Taiwan -
Jih-Kai Huang eric86425@gmail.com Kaohsiung Medical University Hospital Department of Emergency Medicine Kaohsiung Taiwan -
Yun-Shiuan Chuang kinkipag@gmail.com Kaohsiung Medical University Hospital Department of Family Medicine Kaohsiung Taiwan -
Teng-hui Huang sfestg3329@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan -
Ming-Yen Lin mingyenlin3@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan -
Mei-Chuan Kuo mechkuster@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan -
Yi-Wen Chiu chiuyiwen@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan -
Ping-Chi Hsu pchsu@nkust.edu.tw National Kaohsiung University of Science and Technology Department of Safety, Health and Environmental Engineering Kaohsiung Taiwan -
Samira Salihovic Samira.Salihovic@oru.se Örebro University School of Medical Sciences, Faculty of Medicine and Health Örebro Sweden -
Shang-Jyh Hwang sjhwang730136@gmail.com Kaohsiung Medical University Hospital Division of Nephrology, Department of Internal Medicine Kaohsiung Taiwan -
-
-
-
-